But what makes this unique versus the hundreds of other early studies that show "encouraging results"? The technique of CAR-T isn't exactly groundbreaking any more with 3 products already on the market. And the ORR of 59% is kinda of in line with current CAR-Ts.
I'm going to ESMO and this would be interesting but certainly not the highlight of the data releases.
Don't get me wrong, this may turn out to be very exciting, but it's very early data, and similar to other development programs has a 90% chance of failing.
Your initial question was why the link was getting upvotes. I don’t think anyone is claiming it’s a medical revolution but a lot of people have or know someone who has been affected by cancer, and anything which offers hope for the future is going to get attention. I don’t mind that, it’s a pleasant change from yet another JavaScript framework.
I'm going to ESMO and this would be interesting but certainly not the highlight of the data releases.
Don't get me wrong, this may turn out to be very exciting, but it's very early data, and similar to other development programs has a 90% chance of failing.